STING_HUMAN - dbPTM
STING_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID STING_HUMAN
UniProt AC Q86WV6
Protein Name Stimulator of interferon genes protein {ECO:0000303|PubMed:18724357}
Gene Name TMEM173
Organism Homo sapiens (Human).
Sequence Length 379
Subcellular Localization Endoplasmic reticulum membrane
Multi-pass membrane protein . Mitochondrion outer membrane
Multi-pass membrane protein . Cell membrane
Multi-pass membrane protein . Cytoplasm, perinuclear region . Cytoplasm . In response to double-stranded DNA s
Protein Description Facilitator of innate immune signaling that acts as a sensor of cytosolic DNA from bacteria and viruses and promotes the production of type I interferon (IFN-alpha and IFN-beta). Innate immune response is triggered in response to non-CpG double-stranded DNA from viruses and bacteria delivered to the cytoplasm. Acts by recognizing and binding cyclic di-GMP (c-di-GMP), a second messenger produced by bacteria, and cyclic GMP-AMP (cGAMP), a messenger produced in response to DNA virus in the cytosol: upon binding of c-di-GMP or cGAMP, autoinhibition is alleviated and TMEM173/STING is able to activate both NF-kappa-B and IRF3 transcription pathways to induce expression of type I interferon and exert a potent anti-viral state. May be involved in translocon function, the translocon possibly being able to influence the induction of type I interferons. May be involved in transduction of apoptotic signals via its association with the major histocompatibility complex class II (MHC-II). Mediates death signaling via activation of the extracellular signal-regulated kinase (ERK) pathway. Essential for the induction of IFN-beta in response to human herpes simplex virus 1 (HHV-1) infection. Exhibits 2',3' phosphodiester linkage-specific ligand recognition. Can bind both 2'-3' linked cGAMP and 3'-3' linked cGAMP but is preferentially activated by 2'-3' linked cGAMP. [PubMed: 26300263; (Microbial infection) Antiviral activity is antagonized by oncoproteins, such as papillomavirus (HPV) protein E7 and adenovirus early E1A protein]
Protein Sequence MPHSSLHPSIPCPRGHGAQKAALVLLSACLVTLWGLGEPPEHTLRYLVLHLASLQLGLLLNGVCSLAEELRHIHSRYRGSYWRTVRACLGCPLRRGALLLLSIYFYYSLPNAVGPPFTWMLALLGLSQALNILLGLKGLAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
20UbiquitinationPRGHGAQKAALVLLS
CCCCHHHHHHHHHHH
PubMed
84PhosphorylationYRGSYWRTVRACLGC
HCCCHHHHHHHHHCC
27251275
137UbiquitinationLNILLGLKGLAPAEI
HHHHHCCCCCCHHHH
PubMed
150UbiquitinationEISAVCEKGNFNVAH
HHHHHHHCCCCCHHH
19285439
195PhosphorylationNLLRGAVSQRLYILL
HHHHHHHHCCEEEEE
29507054
229PhosphorylationLDKLPQQTGDHAGIK
HHCCCCCCCCCCCCC
24247654
240PhosphorylationAGIKDRVYSNSIYEL
CCCCCCCHHCHHHHH
28450419
241PhosphorylationGIKDRVYSNSIYELL
CCCCCCHHCHHHHHH
28450419
243PhosphorylationKDRVYSNSIYELLEN
CCCCHHCHHHHHHHC
28450419
245PhosphorylationRVYSNSIYELLENGQ
CCHHCHHHHHHHCCC
28450419
289UbiquitinationEDRLEQAKLFCRTLE
HHHHHHHHHHHHHHH
-
338UbiquitinationRHLRQEEKEEVTVGS
HHHHHHHHCCCCCCH
-
342PhosphorylationQEEKEEVTVGSLKTS
HHHHCCCCCCHHCCC
29514088
345PhosphorylationKEEVTVGSLKTSAVP
HCCCCCCHHCCCCCC
29514088
353PhosphorylationLKTSAVPSTSTMSQE
HCCCCCCCCCCCCCC
28857561
354PhosphorylationKTSAVPSTSTMSQEP
CCCCCCCCCCCCCCC
28857561
355PhosphorylationTSAVPSTSTMSQEPE
CCCCCCCCCCCCCCC
28348404
356PhosphorylationSAVPSTSTMSQEPEL
CCCCCCCCCCCCCCE
28348404
358PhosphorylationVPSTSTMSQEPELLI
CCCCCCCCCCCCEEE
28348404
366PhosphorylationQEPELLISGMEKPLP
CCCCEEECCCCCCCC
27302953
370UbiquitinationLLISGMEKPLPLRTD
EEECCCCCCCCCCCC
-
376PhosphorylationEKPLPLRTDFS----
CCCCCCCCCCC----
23090842
379PhosphorylationLPLRTDFS-------
CCCCCCCC-------
23090842

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
358SPhosphorylationKinaseTBK1Q9UHD2
Uniprot
366SPhosphorylationKinaseTBK1Q9UHD2
Uniprot
366SPhosphorylationKinaseULK1O75385
PSP
366SPhosphorylationKinaseULK2Q8IYT8
PSP
-KUbiquitinationE3 ubiquitin ligaseTRIM32Q13049
PMID:22745133
-KUbiquitinationE3 ubiquitin ligaseRNF26Q9BY78
PMID:25254379
-KUbiquitinationE3 ubiquitin ligaseTRIM56Q9BRZ2
PMID:23189823
-KUbiquitinationE3 ubiquitin ligaseRNF5Q99942
PMID:19285439

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
150Kubiquitylation

19285439
150Kubiquitylation

19285439
150Kubiquitylation

19285439
366SPhosphorylation

22394562

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of STING_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
STING_HUMANTMEM173physical
21074459
MRP1_HUMANABCC1physical
21903422
IRAK1_HUMANIRAK1physical
21903422
MBRL_HUMANTMEM259physical
21903422
S61A1_HUMANSEC61A1physical
21903422
TBK1_HUMANTBK1physical
21903422
S39AE_HUMANSLC39A14physical
21903422
ACSL3_HUMANACSL3physical
21903422
CCD47_HUMANCCDC47physical
21903422
CLP1L_HUMANCLPTM1Lphysical
21903422
CNNM3_HUMANCNNM3physical
21903422
OST48_HUMANDDOSTphysical
21903422
GLMN_HUMANGLMNphysical
21903422
HM13_HUMANHM13physical
21903422
MBOA7_HUMANMBOAT7physical
21903422
NPC1_HUMANNPC1physical
21903422
LTN1_HUMANLTN1physical
21903422
SGPL1_HUMANSGPL1physical
21903422
STT3A_HUMANSTT3Aphysical
21903422
STT3B_HUMANSTT3Bphysical
21903422
SURF4_HUMANSURF4physical
21903422
YIPF5_HUMANYIPF5physical
21903422
TRI32_HUMANTRIM32physical
22745133
TBK1_HUMANTBK1physical
22745133
TSN6_HUMANTSPAN6physical
22908223
MAVS_HUMANMAVSphysical
22908223
TOM70_HUMANTOMM70Aphysical
20628368
TBK1_HUMANTBK1physical
24622840
IRF3_HUMANIRF3physical
24622840
IF16_HUMANIFI16physical
20890285
UBP18_HUMANUSP18physical
27801882
TNR5_HUMANCD40physical
27716849
TRAF2_HUMANTRAF2physical
27716849
TRAF3_HUMANTRAF3physical
27716849
NECT4_HUMANPVRL4physical
28514442
TBK1_HUMANTBK1physical
28763789
MUL1_HUMANMUL1physical
28763789
TBK1_HUMANTBK1physical
28346439
IKKE_HUMANIKBKEphysical
28346439

Drug and Disease Associations
Kegg Disease
OMIM Disease
615934STING-associated vasculopathy, infantile-onset (SAVI)
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of STING_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP